As expected, we also found that the aggressive breast cancer cell lines MDA-MB-231 and 4T1 exhibited higher CXCL12/CXCR4 levels than did MCF 10A normal epithelial breast cells. This evidence concerns the gene CXCL12 and breast carcinoma.